BUDA earnings analysis
What we found in BUDA's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Buda Juice delivered strong Q2 revenue growth of 26.4% to $4.508 million, supported by organic growth, Walmart expansion, and the dressings initiative. However, gross margin fell 10.1 percentage points to 36.6%, SG&A rose 179.1%, and net income declined 59.8% to $470 thousand, producing diluted EPS of $0.04. Liquidity is strong following the IPO, with $18.819 million of cash and $20.143 million of working capital, but operating cash flow declined 48.7% to $940 thousand and customer concentration remains substantial at 90% of six-month revenue. The filing states that there were no material changes to the risk factors from the 2025 Form 10-K and provides no quantitative earnings guidance.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Strong Revenue Growth
- Q2 net sales increased 26.4% year over year to $4.508 million from $3.567 million, and rose from $3.508 million in Q1 2026. Management cited same-store organic growth, Buda Fresh distribution into Walmart across 9 states, and a fresh-dressings initiative.
- Private Label Led Product Growth
- Private-label/other revenue grew 40.6% year over year to $2.390 million from $1.700 million, while branded revenue increased to $2.118 million from $1.867 million, a 13.4% increase.
- IPO Strengthened Liquidity
- Cash and cash equivalents increased to $18.819 million from $1.840 million at December 31, 2025, primarily reflecting $16.827 million of net financing cash from the January IPO. The company had no outstanding borrowings and $3.000 million available under its credit facility.
- Substantial Working Capital Cushion
- Working capital increased to $20.143 million from $2.634 million at December 31, 2025, while total current assets rose to $21.561 million from $3.219 million.
- Higher Interest Income
- Interest income increased to $149 thousand from $13 thousand in Q2 2025 and to $286 thousand from $26 thousand for the six-month period, driven by the larger investable cash balance following the IPO.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Severe Gross Margin Compression
- Gross margin declined to 36.6% from 46.7% year over year, as cost of goods sold increased 50.4% to $2.857 million despite revenue growth of 26.4%. Management cited higher inbound freight, diesel-price volatility, interim third-party co-packing, and elevated produce costs.
- Public-Company Cost Burden
- Operating expenses increased 130.8% to $1.207 million, including a 179.1% increase in SG&A to $1.055 million. Operating income fell 61.2% to $444 thousand from $1.144 million, reducing operating margin to approximately 9.8%.
- Working-Capital Cash Drag
- Operating cash flow fell 48.7% to $940 thousand from $1.833 million for the six months ended June 30, 2026. Accounts receivable increased to $1.359 million from $386 thousand at year-end, and management attributed the cash-flow impact partly to a large customer moving from a 1% early-payment discount to net-30 terms.
- Extreme Customer Concentration
- One customer represented approximately $7.145 million, or 90% of six-month revenue, compared with 97% in the prior-year period, leaving the company materially exposed to customer concentration despite the improvement.
- Higher Corporate Tax Load
- Income tax expense increased to $129 thousand in Q2 and $488 thousand for the six-month period, with the six-month effective tax rate at 36.23% versus 0.90% in 2025 following the conversion to a C corporation.
- Rising Investment Requirements
- Capital spending was $688 thousand for the six months, versus $270 thousand in 2025, and management expects planned regional production facilities to represent material investments; future minimum lease payments total $839 thousand through July 2030.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.04
- Gross margin
- 36.6%
- Operating margin
- 9.8%
- Segment
- Single reportable segment: total revenue $4.508 million for Q2 2026 versus $3.567 million in Q2 2025; branded revenue was $2.118 million and private-label/other revenue was $2.390 million.
What they said about what is next.
No explicit quantitative revenue or EPS guidance was provided in the 10-Q. Management stated that planned regional production facilities are expected to require material investment and may be funded with operating cash flow and IPO proceeds.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 14, 2026
- Buda Juice reported Q1 2026 revenue of $3,508,000, reflecting a 17.7% increase compared to $2,980,000 in Q1 2025, while GAAP EPS stood at $0.03. Despite the revenue growth, net income decreased by 52% to $388,000 due to…
- 10-K · March 26, 2026
- Buda Juice reported FY2025 revenue of $12,609,000 and GAAP EPS of $0.20 while recording net profit of $3.53 million for the year ended December 31, 2025. The company positions itself as a category pioneer with an…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing BUDA makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever